Edap Tms SA (EDAP) Upgraded by TheStreet to “Hold”

TheStreet upgraded shares of Edap Tms SA (NASDAQ:EDAP) from a sell rating to a hold rating in a research report report published on Tuesday.

Several other research analysts also recently issued reports on EDAP. Zacks Investment Research upgraded shares of Edap Tms SA from a sell rating to a hold rating in a report on Tuesday, July 19th. HC Wainwright restated a buy rating on shares of Edap Tms SA in a report on Tuesday, August 30th.

Shares of Edap Tms SA (NASDAQ:EDAP) traded up 0.68% during trading on Tuesday, reaching $2.94. 21,761 shares of the company’s stock were exchanged. The company has a market capitalization of $83.17 million, a PE ratio of 17.93 and a beta of 1.58. Edap Tms SA has a 52-week low of $2.43 and a 52-week high of $6.57. The company has a 50 day moving average price of $2.96 and a 200-day moving average price of $3.35.

Edap Tms SA (NASDAQ:EDAP) last announced its earnings results on Thursday, August 25th. The company reported $0.09 EPS for the quarter, topping the consensus estimate of ($0.03) by $0.12. On average, equities analysts forecast that Edap Tms SA will post $0.16 earnings per share for the current year.

An institutional investor recently bought a new stake in Edap Tms SA stock. Perkins Capital Management Inc. bought a new stake in shares of Edap Tms SA (NASDAQ:EDAP) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 118,000 shares of the company’s stock, valued at approximately $391,000. Perkins Capital Management Inc. owned approximately 0.46% of Edap Tms SA at the end of the most recent quarter.

Edap Tms SA Company Profile

EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.

5 Day Chart for NASDAQ:EDAP

Receive News & Ratings for Edap Tms SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms SA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

© 2006-2016 Mideast Time.